Biomarker Platforms Advance Immuno-Oncology
Improved Cancer Immunodiagnostics and Immunotherapeutics Depend on Biomarker Discovery
PCR Optimization 2.0
Optimization of Denaturation Temperature Can Enhance PCR Assays
DNA Fab Keeps Getting More Fab
DNA Fabrication Keeps Improving, Thanks to Innovations in Biosensors, DNA Nanoswitches, and Microfluidic Chips
Reducing the Need for Clinical Bioequivalence Endpoint Studies
Raman Spectroscopy and MDRS Enable Determination of the Size and Shape of Specific Components Within a Multicomponent Blend
For full access to this article login to GEN Select now.
Simplifying Complex Biological Matrices
- Protein therapeutics is a fast-growing segment within the global pharmaceutical industry. Six thousand biologic drugs were in clinical trials in 2009 compared to 1,200 in 2005. By 2014, six of the top 10 drugs on the market will be biologics, according to a 2011 Thompson Reuters–Newport study of U.S. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.